Rosanne E. Veerman

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks.

Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks.

Journal: NPJ precision oncology

Published: February 12, 2026

Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange.

Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange.

Journal: International journal of biological macromolecules

Published: August 27, 2025

Corrigendum to "Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer" [Cancer Lett 609 (2025) 217352].

Corrigendum to "Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer" [Cancer Lett 609 (2025) 217352].

Journal: Cancer letters

Published: June 30, 2025

Corrigendum to "Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer" [Cancer Lett. 609 (2025) 217352].

Corrigendum to "Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer" [Cancer Lett. 609 (2025) 217352].

Journal: Cancer letters

Published: March 06, 2025

Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer.

Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer.

Journal: Cancer letters

Published: September 30, 2024

A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice.

A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice.

Journal: Nature communications

Published: July 04, 2023

Antigen-Loaded Extracellular Vesicles Induce Responsiveness to Anti-PD-1 and Anti-PD-L1 Treatment in a Checkpoint Refractory Melanoma Model.

Antigen-Loaded Extracellular Vesicles Induce Responsiveness to Anti-PD-1 and Anti-PD-L1 Treatment in a Checkpoint Refractory Melanoma Model.

Journal: Cancer immunology research

Published: July 11, 2022

Surgical Trauma in Mice Modifies the Content of Circulating Extracellular Vesicles.

Surgical Trauma in Mice Modifies the Content of Circulating Extracellular Vesicles.

Journal: Frontiers in immunology

Published: November 29, 2021

Proteomic Profiling of Tissue Exosomes Indicates Continuous Release of Malignant Exosomes in Urinary Bladder Cancer Patients, Even with Pathologically Undetectable Tumour.

Proteomic Profiling of Tissue Exosomes Indicates Continuous Release of Malignant Exosomes in Urinary Bladder Cancer Patients, Even with Pathologically Undetectable Tumour.

Journal: Cancers

Published: May 07, 2021

Molecular evaluation of five different isolation methods for extracellular vesicles reveals different clinical applicability and subcellular origin.

Molecular evaluation of five different isolation methods for extracellular vesicles reveals different clinical applicability and subcellular origin.

Journal: Journal of extracellular vesicles

Published: January 18, 2021

Extracellular Vesicles Released From the Skin Commensal Yeast Malassezia sympodialis Activate Human Primary Keratinocytes.

Extracellular Vesicles Released From the Skin Commensal Yeast Malassezia sympodialis Activate Human Primary Keratinocytes.

Journal: Frontiers in cellular and infection microbiology

Published: September 30, 2019

Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging.

Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging.

Journal: Scientific reports

Published: May 28, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026